Clinical Trials Logo

Filter by:
NCT ID: NCT01773213 Completed - Clinical trials for Urinary Bladder, Neurogenic

Detrusor Contraction During the Ice-water-test

Start date: December 2012
Phase: N/A
Study type: Interventional

In this randomized, double-blind clinical trial including patients with a neurogenic lower urinary tract dysfunction undergoing urodynamic investigation at the Spinal Cord Injury Center, Balgrist University Hospital, Zürich, we aim to investigate whether the detrusor contraction during the ice-water-test is provoked by the ice water or the rapid filling.

NCT ID: NCT01772914 Completed - Healthy Adults Clinical Trials

Copeptin Changes After Food Intake

CoMeal
Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether copeptin levels are affected by food intake.

NCT ID: NCT01772888 Completed - Clinical trials for Amyotrophic Lateral Sclerosis 11

Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?

Start date: October 2012
Phase:
Study type: Observational

Study aims: The primary aim is to determine whether chewing efficiency, determined by a two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.

NCT ID: NCT01772784 Completed - Healthy Clinical Trials

Effects of Phenolic Acids on Endothelial Function

Start date: June 2012
Phase: N/A
Study type: Interventional

Epidemiological studies suggest dietary (poly) phenols decrease the risk of death from cardiovascular diseases. (Poly)phenol-rich foods include fruits and vegetables as well as tea, coffee, red wine, and chocolate. The aim of the present study is to investigate whether endothelial function is altered by ingestion of phenolic acids. Moreover, the investigators will evaluate the effect of phenolic acids on blood pressure and platelet adhesion.

NCT ID: NCT01772472 Active, not recruiting - Breast Cancer Clinical Trials

A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)

Start date: April 3, 2013
Phase: Phase 3
Study type: Interventional

This 2-arm, randomized, open-label study will evaluate the efficacy and safety of trastuzumab emtansine versus trastuzumab as adjuvant therapy in patients with HER2-positive breast cancer who have residual tumor present in the breast or axillary lymph nodes following preoperative therapy. Eligible patients will be randomized to receive either trastuzumab emtansine 3.6 mg/kg or trastuzumab 6 mg/kg intravenously every 3 weeks for 14 cycles. Radiotherapy and/or hormone therapy will be given in addition if indicated.

NCT ID: NCT01772108 Terminated - Clinical trials for Cardiovascular Diseases

A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation

RESHAPE-HF
Start date: April 2013
Phase: N/A
Study type: Interventional

This trial is a randomized study of the MitraClip device in heart failure patients with clinically significant functional mitral regurgitation. A hierarchical composite of all-cause mortality and recurrent heart failure hospitalizations is hypothesized to occur at a lower rate with the use of the MitraClip device in addition to optimal standard medical therapy compared to optimal standard of care therapy alone.

NCT ID: NCT01771874 Completed - Healthy Clinical Trials

Influence of Bupropion on the Effects of MDMA

Start date: January 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determinate the effect of a pre-treatment with bupropion, a dopamine and norepinephrine transporter inhibitor, on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). The study will provide further understanding of the dopaminergic regulation of mood.

NCT ID: NCT01771835 Completed - Diabetes Mellitus Clinical Trials

Retinal Venous Pressure and ET-1 in Patients With Diabetes Mellitus

Start date: August 2011
Phase: N/A
Study type: Observational

Measurement of the circulation in patients with diabetes mellitus and establish a link between retinal venous pressure (RVP) and endothelin (ET-1)levels.

NCT ID: NCT01771783 Completed - Clinical trials for RAS Peptide Profile in Healthy Volunteers

RAS-Peptide-Profile Study in Healthy Male Subjects

RAS
Start date: November 2012
Phase: Phase 1
Study type: Interventional

The primary objective is the characterization of the RAS peptide profiles after single and repeated oral administration of a renin inhibitor, an ACE inhibitor and an angiotensin receptor blocker in healthy volunteers. Secondary objectives are the correlation of RAS peptide profiles with pharmacokinetic profiles of the different RAS inhibitors and with pharmacodynamic parameters such as blood pressure and heart rate. Output of the classic RAS system will be assessed using aldosterone concentrations. Fluid and sodium intake will be monitored using sodium concentration and total volume in 24h urine.

NCT ID: NCT01771770 Completed - Healthy Clinical Trials

Measurement of Retinal Venous Pressure in Chronic Low-oxygen Environment

Start date: December 2011
Phase: N/A
Study type: Observational

The hypothesis is that the pressure in the retinal veins increases from chronic lack of oxygen and leads to decreased blood flow. On the basis of high altitude mountaineering this hypothesis should be verified. At the same time the adaptation capacity of the blood circulation should be analyzed, and a relationship to mountain sickness should be found.